Indian Journal of Microbiology

, Volume 58, Issue 2, pp 174–181 | Cite as

Cloning of ompA gene from Acinetobacter baumannii into the eukaryotic expression vector pBudCE4.1 as DNA vaccine

  • Hossein Ansari
  • Abbas Doosti
  • Mohammad Kargar
  • Mahdi Bijanzadeh
  • Mojtaba Jaafarinia
Original Research Article


Antibiotic resistant features of Acinetobacter baumannii is partly due to the decreased outer membrane proteins (OMPs) permeability. The OmpA is one of the most conserved proteins among A. baumannii with a considerable antigenic potential to stimulate the multidimensional immune system responses. The present study was aimed to clone the ompA gene into the eukaryotic expression vector with potential as DNA vaccine. The ompA gene of A. baumannii was amplified using polymerase chain reaction (PCR). The target DNA was cloned and sub-cloned into the pTZ57R/T and pBudCE4.1 vectors, respectively. The recombinant vectors containing ompA were then validated using colony PCR, vector sequencing and double-digestion strategies. The pBudCE4.1ompA recombinant plasmid was transfected into the human dermal fibroblast cells (HDF) and presence of ompA transcript and protein was evaluated using reverse transcribed-PCR (RT-PCR) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Our finding from colony PCR, sequencing and enzyme double digestion result confirmed that target gene has been successfully inserted into the pTZ57RT and pBudCE4.1. The presence of an expected band (1112 bp) in RT-PCR as wells as a ~ 38 kDa band during SDS-PAGE showed that the recombinant pBudCE4.1ompA construct was efficiently transfected into the HDF cells and expressed. Altogether, our observation demonstrated that the recombinant pBudCE4.1ompA construct was successfully produced although further experiments are needed.


DNA vaccine Acinetobacter baumannii Outer membrane protein ompA gene 


A. baumanni

Acinetobacter baumanni


Complementary DNA


Dulbecco’s modified Eagle’s medium


Ethylenediaminetetraacetic acid


Fetal calf serum




Granulocyte-macrophage colony-stimulating factor




Human dermal fibroblast


Infectious Diseases Society of America










Multidrug resistance


Negative control


Outer membrane protein


Outer membrane protein A


Outer membrane vesicles


Polymerase chain reaction


Polysaccharide poly-N-acetyl-β-(1-6)-glucosamine


Reverse transcription polymerase chain reaction




Sodium dodecyl sulfate polyacrylamide gel electrophoresis





This study is part of Ph.D. thesis which was granted by Fars Science and Research Branch, Islamic Azad University, Shiraz, I. R. Iran. The Authors are thankful from Farzam Latifi and all the colleagues in Biotechnology Research Center, Islamic Azad University Shahrekord for their gorgeous assistant in this project.

Authors Contribution

HA; literature review, manuscript writing and data collection. AD; literature review and manuscript revision, MK; manuscript revision, MB; manuscript revision and data collection and MJ; literature review.

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Singh R, Garg N, Shukla G, Capalash N, Sharma P (2016) Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate. Front Microbiol 7:158. PubMedPubMedCentralGoogle Scholar
  2. 2.
    Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N (2011) Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 3:68–74PubMedPubMedCentralGoogle Scholar
  3. 3.
    Japoni-Nejad A, Sofian M, van Belkum A, Ghaznavi-Rad E (2013) Nosocomial outbreak of extensively and pan drug-resistant Acinetobacter baumannii in tertiary hospital in central part of Iran. Jundishapur J Microbiol 6:e9892. CrossRefGoogle Scholar
  4. 4.
    Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG (2006) Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis 42:657–668. CrossRefPubMedGoogle Scholar
  5. 5.
    Viehman JA, Nguyen MH, Doi Y (2014) Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacterbaumannii infections. Drugs 74:1315–1333. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nowak J, Seifert H, Higgins P (2015) Prevalence of eight RND-efflux pump genes in epidemiologically characterised Acinetobacter baumannii of worldwide origin. J Med Microbiol 64:630–635. CrossRefPubMedGoogle Scholar
  7. 7.
    Manchanda V, Sanchaita S, Singh N (2010) Multidrug resistant acinetobacter. J Glob Infect Dis 2:291. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Almasaudi SB (2016) Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci. PubMedPubMedCentralGoogle Scholar
  9. 9.
    Huang W, Yao Y, Wang S, Xia Y, Yang X, Long Q, Sun W, Liu C, Li Y, Chu X (2016) Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Sci Rep 6:20724. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Smani Y, Fàbrega A, Roca I, Sánchez-Encinales V, Vila J, Pachón J (2014) Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother 58:1806–1808. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    King LB, Swiatlo E, Swiatlo A, McDaniel LS (2009) Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol 55:414–421. CrossRefPubMedGoogle Scholar
  12. 12.
    Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin J-H, Kim JM, Lee YC, Seol SY, Cho DT (2009) Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 301:224–231. CrossRefPubMedGoogle Scholar
  13. 13.
    Smith SG, Mahon V, Lambert MA, Fagan RP (2007) A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol Lett 273:1–11. CrossRefPubMedGoogle Scholar
  14. 14.
    Sambrook J, Russell DW (2006) Preparation and transformation of competent E. coli using calcium chloride. Cold Spring Harb Protoc. Google Scholar
  15. 15.
    Singh R, Garg N, Capalash N, Kumar R, Kumar M, Sharma P (2014) In silico analysis of Acinetobacter baumannii outer membrane protein BamA as a potential immunogen. Int J Pure Appl Sci Technol 21:32–39Google Scholar
  16. 16.
    AL-Warid RJ, AL-Thahab AA (2014) Cellular immune response to outer membrane proteins isolated from Acinetobacter baumannii. Int J Res Appl Nat Soc Sci 2:91–96Google Scholar
  17. 17.
    Badmasti F, Ajdary S, Bouzari S, Fooladi AAI, Shahcheraghi F, Siadat SD (2015) Immunological evaluation of OMV (PagL)+ Bap (1-487aa) and AbOmpA (8-346aa)+ Bap (1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection. Mol Immunol 67:552–558. CrossRefPubMedGoogle Scholar
  18. 18.
    Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T (2012) Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun 80:3381–3388. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, Michael FS, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA (2013) The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 81:915–922. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Li L, Saade F, Petrovsky N (2012) The future of human DNA vaccines. J Biotechnol 162:171–182. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Li L, Petrovsky N (2016) Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 15:313–329. CrossRefPubMedGoogle Scholar
  22. 22.
    Pereira VB, Zurita-Turk M, Saraiva TDL, De Castro CP, Souza BM, Agresti PM, Lima FA, Pfeiffer VN, Azevedo MSP, Rocha CS (2014) DNA vaccines approach: from concepts to applications. World J Vaccines 4:50–71. CrossRefGoogle Scholar
  23. 23.
    Chen T-L, Lee Y-T, Kuo S-C, Yang S-P, Fung C-P, Lee S-D (2014) Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay. J Med Microbiol 63:1154–1159. CrossRefPubMedGoogle Scholar
  24. 24.
    Fournier PE, Richet H, Weinstein RA (2006) The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42:692–699. CrossRefPubMedGoogle Scholar
  25. 25.
    Ansari H, Doosti A, Kargar M, Bijanzadeh M, Jafarinya M (2017) Antimicrobial resistant determination and prokaryotic expression of smpA gene of Acinetobacter baumannii isolated from admitted patients. Jundishapour J Microbiol (accepted)Google Scholar
  26. 26.
    McConnell MJ, Rumbo C, Bou G, Pachón J (2011) Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine 29:5705–5710. CrossRefPubMedGoogle Scholar
  27. 27.
    Fattahian Y, Rasooli I, Gargari SLM, Rahbar MR, Astaneh SDA, Amani J (2011) Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 51:402–406. CrossRefPubMedGoogle Scholar
  28. 28.
    Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA (2010) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78:3993–4000. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Bentancor LV, O’Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T (2012) Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun 80:651–656. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Moriel DG, Beatson SA, Wurpel DJ, Lipman J, Nimmo GR, Paterson DL, Schembri MA (2013) Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS ONE 8:e77631. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B (2012) Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS ONE 7:e29446. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B (2013) Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes. Vaccine 31:313–318. CrossRefPubMedGoogle Scholar
  33. 33.
    Alzubaidi AN, Alkozai ZM (2015) Immunogenic properties of outer membrane protein of Acinetobacter baumannii that loaded on chitosan nanoparticles. Am J BioMed 3:59–74Google Scholar

Copyright information

© Association of Microbiologists of India 2018

Authors and Affiliations

  • Hossein Ansari
    • 1
    • 5
  • Abbas Doosti
    • 2
  • Mohammad Kargar
    • 3
  • Mahdi Bijanzadeh
    • 4
  • Mojtaba Jaafarinia
    • 5
  1. 1.Department of Molecular Genetics, Fars Science and Research BranchIslamic Azad UniversityShirazIslamic Republic of Iran
  2. 2.Biotechnology Research Center, Shahrekord BranchIslamic Azad UniversityShahrekordIslamic Republic of Iran
  3. 3.Department of Microbiology, Jahrom BranchIslamic Azad UniversityJahromIslamic Republic of Iran
  4. 4.Department of Medical Genetics, School of MedicineAhvaz Jundishapur University of Medical SciencesAhvazIslamic Republic of Iran
  5. 5.Department of Molecular Genetics, Marvdasht BranchIslamic Azad UniversityMarvdashtIslamic Republic of Iran

Personalised recommendations